Madrigal Pharmaceuticals Inc (MDGL)
215.99
+5.91
(+2.81%)
USD |
NASDAQ |
May 02, 16:00
215.99
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals Free Cash Flow (Quarterly): -80.97M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -80.97M |
| September 30, 2023 | -85.26M |
| June 30, 2023 | -75.38M |
| March 31, 2023 | -84.10M |
| December 31, 2022 | -58.54M |
| September 30, 2022 | -59.10M |
| June 30, 2022 | -57.46M |
| March 31, 2022 | -49.96M |
| December 31, 2021 | -48.16M |
| September 30, 2021 | -45.61M |
| June 30, 2021 | -46.88M |
| March 31, 2021 | -43.47M |
| December 31, 2020 | -54.96M |
| September 30, 2020 | -47.85M |
| June 30, 2020 | -24.26M |
| March 31, 2020 | -30.82M |
| December 31, 2019 | -12.42M |
| September 30, 2019 | -11.32M |
| June 30, 2019 | -11.54M |
| March 31, 2019 | -6.519M |
| December 31, 2018 | -6.273M |
| September 30, 2018 | -5.251M |
| June 30, 2018 | -5.36M |
| March 31, 2018 | -8.645M |
| December 31, 2017 | -5.945M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.951M |
| June 30, 2017 | -7.773M |
| March 31, 2017 | -3.773M |
| December 31, 2016 | -5.282M |
| September 30, 2016 | -9.244M |
| June 30, 2016 | -2.647M |
| March 31, 2016 | -0.438M |
| December 31, 2015 | -1.096M |
| September 30, 2015 | 34.49M |
| June 30, 2015 | -17.76M |
| March 31, 2015 | -18.78M |
| December 31, 2014 | -19.27M |
| September 30, 2014 | -18.60M |
| June 30, 2014 | -20.90M |
| March 31, 2014 | -20.29M |
| December 31, 2013 | -18.77M |
| September 30, 2013 | -16.60M |
| June 30, 2013 | -20.31M |
| March 31, 2013 | -22.49M |
| December 31, 2012 | -12.61M |
| September 30, 2012 | -13.47M |
| June 30, 2012 | -13.16M |
| March 31, 2012 | -15.40M |
| December 31, 2011 | -10.87M |
| September 30, 2011 | -12.08M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-85.26M
Minimum
Sep 2023
-11.32M
Maximum
Sep 2019
-48.85M
Average
-48.16M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly and Co | 83.20M |
| Viking Therapeutics Inc | -6.134M |
| Akero Therapeutics Inc | -48.63M |
| 89bio Inc | -34.29M |
| Geron Corp | -41.00M |